Under construction – not a live service
Sign in
Taking people in SingaporeNo phase

Testing an Education Program to Help People Check Their Own Skin for Cancer

Tests a skin cancer self-checking education program, including gain versus loss messaging.

Plain-language title generated from the registry record
Registry title: Developing and Testing the Effectiveness of a Skin Cancer Self-Detection Educational Program

Key facts

Where
Singapore, SingaporeSee the site

Where in Singapore

  • National University HospitalSingapore, SingaporeTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
National University Hospital, Singapore
Trial code
NCT07247123
Record updated
24 September 2026
Original description
Skin cancer is a significant public health concern, even in an Asian society like Singapore where it ranks among the top 10 cancers. This RCT tests the effectiveness of a skin cancer educational intervention to improve skin cancer outcomes among skin-of-color individuals, including the effects of gain versus loss framing.Read full original descriptionShow less

Protocol for Developing and Testing the Effectiveness of a Skin Cancer Self-Detection Educational Program: A Randomised Controlled Trial

Skin cancer is a significant public health concern, even in an Asian society like Singapore where it ranks among the top 10 cancers. This RCT tests the effectiveness of a skin cancer educational intervention to improve skin cancer outcomes among skin-of-color individuals, including the effects of gain versus loss framing.

Inclusion: Individuals aged 16 and above; Able to read and converse in English; Able to provide informed consent; Having the ability to use and interact with a web server or application.

Exclusion: Individuals who have cognitive impairment or decline to participate. There will be no exclusion criteria based on a previous history of skin cancer.

ClinicalTrials.gov NCT07247123